Re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.05.031 (European Urology)
We read with great interest the report by Calaway et al [1] and their note of caution regarding the use of robotic retroperitoneal lymph node dissection (RPLND) for men with testis cancer. For their retrospective case series of five patients referred for management of recurrent intra-abdominal disease following robotic RPLND, the authors suggest that these unusual recurrence patterns were secondary to the robotic approach.